Spectrum Pharmaceuticals Inc
SPPIDelisted Aug 1, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000831547
Spectrum Pharmaceuticals Inc was delisted on Aug 1, 2023; its insiders filed their last Form 4 on Aug 1, 2023; 78 institutions reported holding it in 13F filings for Q2 2023, worth $56.5M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Spectrum Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Spectrum Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ashton William | Director | 0 | Aug 1, 2023 | 0 |
| Fischer Seth H. Z. | Director | 0 | Aug 1, 2023 | 0 |
| Vacirca Jeff L | Director | 0 | Aug 1, 2023 | 0 |
| Riga Thomas J | See Remarks | 0 | Aug 1, 2023 | 0 |
| McGahan Keith M | See Remarks | 0 | Aug 1, 2023 | 0 |
| Brennan Nora | See Remarks | 0 | Aug 1, 2023 | 0 |
| Bradrick Brittany | Director | 0 | Aug 1, 2023 | 0 |
| Lim Juhyun | Director | 0 | Aug 1, 2023 | 0 |
| Lebel Francois | Chief Medical Officer | 644,790 | Jun 23, 2022 | 0 |
| Vyas Dolatrai | Other: Former Director | 82,063 | Jun 22, 2022 | 0 |
| Gustafson Kurt A | EVP & Chief Financial Officer | 317,259 | Mar 16, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2023 (view filing) | May 26 | 4 days | Brennan NoraCFO | SSaleCommon Stock, $0.001 par value | −32.4K | $1.10 | −$35.6K | −5.4%567.8K after | |
| Mar 17, 2023 (view filing) | Mar 14-15 | 3 daysLate | McGahan Keith MChief Legal Officer | SSaleCommon Stock, $0.001 par value | −42.9K | $0.8073 | −$34.7K | −18.5%189.3K after | 2 lots |
| Mar 17, 2023 (view filing) | Mar 14-15 | 3 daysLate | Riga Thomas JCEO & President | SSaleCommon Stock, $0.001 par value | −49.5K | $0.8073 | −$40.0K | −9.5%472.4K after | 2 lots |
| Feb 24, 2023 (view filing) | Feb 22-23 | 2 days | McGahan Keith MChief Legal Officer | SSaleCommon Stock, $0.001 par value | −30.4K | $0.7661 | −$23.3K | −4.7%618.3K after | 2 lots |
| Feb 24, 2023 (view filing) | Feb 22 | 2 days | Riga Thomas JCEO & President | SSaleCommon Stock, $0.001 par value | −37.0K | $0.7661 | −$28.4K | −2.0%1.84M after | 2 lots |
| Feb 1, 2023 (view filing) | Jan 30-31 | 2 days | McGahan Keith MChief Legal Officer | SSaleCommon Stock, $0.001 par value | −67.2K | $0.5889 | −$39.5K | −9.4%645.9K after | 2 lots |
| Feb 1, 2023 (view filing) | Jan 30-31 | 2 days | Riga Thomas JCEO & President | SSaleCommon Stock, $0.001 par value | −176.8K | $0.6129 | −$108.4K | −8.5%1.90M after | 2 lots |
| Jan 5, 2023 (view filing)7:50 PM ET | Jan 3 | 2 days | Riga Thomas JCEO & President | SSaleCommon Stock, $0.001 par value | −23.9K | $0.382 | −$9.14K | −2.0%1.19M after | |
| Dec 2, 2022 (view filing)8:17 PM ET | Nov 30 | 2 days | Vacirca Jeff LDirector | PPurchaseCommon Stock, $0.001 par value | +50.0K | $0.45 | +$22.5K | +22.7%270.2K after | |
| Jun 23, 2022 (view filing) | Jun 22-23 | 1 day | Lebel FrancoisChief Medical Officer | SSaleCommon Stock, $0.001 par value | −12.8K | $0.8257 | −$10.5K | −1.9%644.8K after | 2 lots |
| Jun 23, 2022 (view filing) | Jun 21 | 2 days | Brennan NoraEVP & CFO | SSaleCommon Stock, $0.001 par value | −3.57K | $0.79 | −$2.82K | −1.0%360.2K after | |
| Jun 22, 2022 (view filing) | Jun 21 | 1 day | Fischer Seth H. Z.Director | SSaleCommon Stock, $0.001 par value | −5.71K | $0.79 | −$4.51K | −16.4%29.1K after | |
| Jun 22, 2022 (view filing) | Jun 21 | 1 day | Vyas DolatraiOther: Former Director | SSaleCommon Stock, $0.001 par value | −4.28K | $0.79 | −$3.38K | −5.0%82.1K after | |
| Jun 22, 2022 (view filing) | Jun 21 | 1 day | Ashton WilliamDirector | SSaleCommon Stock, $0.001 par value | −4.28K | $0.79 | −$3.38K | −9.1%42.7K after | |
| Apr 5, 2022 (view filing) | Apr 4-5 | 1 day | Lebel FrancoisChief Medical Officer | SSaleCommon Stock, $0.001 par value | −2.57K | $1.38 | −$3.55K | −1.0%252.5K after | 2 lots |
| Mar 16, 2022 (view filing) | Mar 15-16 | 1 day | Lebel FrancoisChief Medical Officer | SSaleCommon Stock, $0.001 par value | −50.2K | $0.71 | −$35.7K | −16.5%255.1K after | 2 lots |
| Mar 16, 2022 (view filing) | Mar 15-16 | 1 day | McGahan Keith MChief Legal Officer | SSaleCommon Stock, $0.001 par value | −31.0K | $0.71 | −$22.0K | −11.2%244.9K after | 2 lots |
| Mar 16, 2022 (view filing) | Mar 15-16 | 1 day | Riga Thomas JCEO & President | SSaleCommon Stock, $0.001 par value | −39.2K | $0.71 | −$27.8K | −6.4%568.8K after | 2 lots |
| Mar 16, 2022 (view filing) | Mar 15-16 | 1 day | Gustafson Kurt AEVP & Chief Financial Officer | SSaleCommon Stock, $0.001 par value | −37.0K | $0.71 | −$26.2K | −10.4%317.3K after | 2 lots |
| Feb 24, 2022 (view filing) | Feb 23-24 | 1 day | Lebel FrancoisChief Medical Officer | SSaleCommon Stock, $0.001 par value | −28.2K | $0.6687 | −$18.8K | −8.4%305.3K after | 2 lots |
| Feb 24, 2022 (view filing) | Feb 23-24 | 1 day | Riga Thomas JCEO & President | SSaleCommon Stock, $0.001 par value | −38.4K | $0.6712 | −$25.8K | −5.9%608.0K after | 2 lots |
| Feb 24, 2022 (view filing) | Feb 23-24 | 1 day | McGahan Keith MChief Legal Officer | SSaleCommon Stock, $0.001 par value | −28.5K | $0.6684 | −$19.1K | −9.4%275.9K after | 2 lots |
| Feb 24, 2022 (view filing) | Feb 23-24 | 1 day | Gustafson Kurt AEVP & Chief Financial Officer | SSaleCommon Stock, $0.001 par value | −36.2K | $0.6735 | −$24.4K | −9.3%354.2K after | 2 lots |
| Nov 10, 2021 (view filing) | Nov 8-9 | 2 days | Lebel FrancoisChief Medical Officer | SSaleCommon Stock, $0.001 par value | −13.4K | $2.19 | −$29.3K | −3.9%329.2K after | 2 lots |